CD4 and tuberculosis: At 8 weeks post RR-TB treatment initiation, 28 patients known to be in clinical care and eligible for ART (median CD4 count 116 cells/mm3) were not yet initiated; by 16 weeks, 16 patients remaining in care and eligible (median CD4 count 132 cells/mm3) were still not initiated on ART.